LATEST ALERTS
Bank associations pressure US Congress for cannabis banking reform
29th May 2019 - News analysis |
Banking associations from all across the US have written to the Senate to advocate for a hearing on cannabis banking reform
Policy and Politics
CBD business news in brief: worldwide, 20-24th May 2019
27th May 2019 - News analysis |
Catch up on the latest CBD business news with CBD-Intel’s weekly round-up of stories.
What will European Parliament elections mean for CBD?
23rd May 2019 - News analysis |
Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation
CBD and cannabis news in brief: International
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station
CBD and cannabis news in brief: Europe
20th May 2019 - News analysis , Regulatory alerts roundup |
The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU
Tennessee brings ‘smoking hemp’ into its legal lexicon
17th May 2019 - News analysis |
The Tennessee legislature has enacted a bill which defines “smoking hemp”
Government funding puts wind in the sails of Irish CBD companies
16th May 2019 - News analysis |
Funding is available for Irish CBD businesses from Enterprise Ireland, a government body facilitating business development
Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat
16th May 2019 - News analysis |
The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry
Legal CBD firms face cash chaos as US Bank cancels their card accounts
14th May 2019 - News analysis |
Elavon Inc, a subsidiary of US Bank that processes card transactions, will cancel payment services for CBD businesses this week, documents seen by CBD-Intel reveal
New Zealand’s recreational cannabis referendum won’t affect CBD
9th May 2019 - News analysis |
A decision on legalising recreational cannabis in New Zealand will go to a referendum to be held next year, but the outcome is not likely to affect the regulatory status of CBD
US veterans at odds with federal agency over legalising clinical trials
8th May 2019 - News analysis |
The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis
CBD is a feminist issue too as women take a progressive leading role
1st May 2019 - News analysis |
Women are emerging as key players in the movement to promote medical CBD: starting their own businesses, campaigning for legalisation and creating networks for future empowerment
Hemp growing on the rise, but Ireland still sends abroad for medical supplies
25th April 2019 - News analysis |
Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme
Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP
24th April 2019 - News analysis |
A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families
Mexican legalisation may come with added regulation and controls
18th April 2019 - News analysis |
Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime
Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’
17th April 2019 - News analysis |
Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard
US attorney general favours bid to let states decide cannabis and CBD policy
16th April 2019 - News analysis |
US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies
Questions in UK parliament after medical cannabis is seized at airport
9th April 2019 - News analysis |
Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard
US Postal Service offers guidance on mail delivery of CBD products
4th April 2019 - News analysis |
Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue
Ohio Senate passes bill to establish CBD market, as Texas delists hemp
3rd April 2019 - News analysis |
Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances
UK government loses a pro-cannabis minister as Brine exits over Brexit
3rd April 2019 - News analysis |
UK member of parliament Steve Brine, a supporter of medical cannabis, has resigned as under-secretary of state for public health over Brexit-related issues
Mainstream US drugstore chains announce plans to sell CBD
29th March 2019 - News analysis |
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.
Philippines moves one step closer to legalising medical cannabis
29th March 2019 - News analysis |
The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.
Leading UK specialist calls for medical cannabis trials – NICE says yes
28th March 2019 - News analysis |
The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed
A guide to EU novel food rules for cannabinoid-containing edibles
26th March 2019 - Regulatory reports |
Under current EU rules, cannabinoid-containing hemp extracts could require pre-market authorisation as they are now considered to be novel foods. CBD-Intel explains how the rules work
Cannabis troubles – UK committee hears of inconsistency and confusion
26th March 2019 - News analysis |
Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Cannabis is popular left, right and centre as Israeli election approaches
22nd March 2019 - News analysis |
Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis
There’s room yet for growth and untangling in Canada’s legal reform
18th March 2019 - News analysis |
Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains
Will European authorities change their view of cannabinoids?
15th March 2019 - News analysis |
Lobbyists have highlighted flaws in European authorities’ current classification of cannabinoids as novel foods which could signal change
State by state, US Farm Bill delivers different strokes for different folks
4th March 2019 - News analysis |
Several US states and territories are reporting changes to hemp policies following the passing of the 2018 US Farm Bill. One surprisingly positive example is Pennsylvania, which is backing growth
GW Pharmaceuticals reports loss despite success of CBD-based drug
1st March 2019 - News analysis |
CBD drug manufacturer GW Pharmaceuticals saw a significant net loss in the last quarter, despite growth and sales of its cannabis-derived pharmaceutical drugs going to plan
FDA jurisdiction still unchallenged – but industry presses for clarity
1st March 2019 - News analysis |
The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light
CBD in foods: UK FSA set to issue guidance
1st March 2019 - News analysis |
The UK Food Standards Agency (FSA) will issue further guidance next week on the use of cannabinoids as novel food ingredients
FDA sets the date for hearing on legalising hemp-derived CBD
1st March 2019 - News analysis |
The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb
Swiss report signals ‘the beginning of the end of cannabis prohibition’
28th February 2019 - News analysis |
Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts
Confusion abounds in the tangle of US states’ CBD enforcement
26th February 2019 - News analysis |
Momentum in the American CBD market continues to build, but a confusing patchwork of differing interpretations by various state authorities has led to local officials starting to clamp down on retailers
UN narcotics committee postpones vote on CBD and cannabis rules
26th February 2019 - News analysis |
The United Nations Committee on Narcotic Drugs (UNCND) has delayed voting on cannabis and CBD recommendations in a move that has upset a number of delegates
How will Spanish elections change the outlook for CBD and cannabis?
26th February 2019 - News analysis |
Whether the left or the right ends up in power – and that is difficult to predict – some form of debate around cannabis could be on the cards following forthcoming general elections in Spain
Global CBD rules will get tougher, then normalise, expert predicts
20th February 2019 - News analysis |
Regulations governing hemp-derived CBD are likely to increase sharply in the near future but then tail off as the product is integrated into general regulatory frameworks for food, cosmetics and industrial products, according to a legal expert
Singapore ministries declare cannabis mad, bad and dangerous
18th February 2019 - News analysis |
Singaporean authorities do not believe there is sufficient evidence supporting the efficacy of “raw” cannabis, considering the plant and its derivatives to be a dangerous drug with few medical benefits
Europe votes for medical cannabis – in theory and on certain conditions
14th February 2019 - News analysis |
The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process
‘No change to UK novel food rules’ after Brexit
8th February 2019 - News analysis |
The UK’s Food Standards Agency has said there will be no change in UK regulations concerning CBD as a novel food ingredient should the UK leave the EU on 29th March
Israel can grow its cannabis and CBD sector with government blessing
7th February 2019 - News analysis |
Although cannabis is considered a dangerous drug in Israel, government support for cannabis start-ups and liberal policies on research have helped the country develop an active medical cannabis industry
Greek enforcement hurdles hamper but don’t shut down opportunities
6th February 2019 - News analysis |
Interest in the Greek CBD market continues to grow despite an uncertain regulatory situation, with a number of apparent cases of police taking action against people acting entirely legally
CBD in Sweden: regulatory snapshot
5th February 2019 - Regulatory reports |
This report covers the regulatory status of CBD-related products in Sweden
While the EU has allowed varieties of industrial hemp to be grown in Sweden in accordance with EU rules, cannabidiol extracts are currently widely subject to medicines legislation as interpreted by Sweden’s Medical Products Agency.
Israel gears up for trade after cannabis export law is passed
5th February 2019 - News analysis |
Israeli firms will soon be able to export medical cannabis and some derived medical cannabis products after a bill was passed establishing a licensing and supervision regime
Knotty regulation keeps CBD traffic still tied up on state lines
4th February 2019 - News analysis |
Despite the 2018 Farm Act, CBD companies hoping for a national market in the US are still hampered by federal regulations, with products prevented from being sold across state lines
Argentina – land of opportunity beset by confusion and doubt
29th January 2019 - News analysis |
A growing domestic CBD consumer base and excellent potential for cannabis farming make Argentina an intriguing market despite regulatory ambiguity and differences in opinion between national and provincial authorities
US veterans urge CBD legalisation in Georgia, Tennessee drafts CBD bills
28th January 2019 - News analysis |
Congressional politicians in Tennessee have been turning their attention to possible regulation of farming for CBD, while those in Georgia have been addressed by military veterans eager for CBD to be legalised
CBD classed as pharmaceutical product: Taiwan regulatory report
24th January 2019 - Regulatory reports |
In our report looking at the regulations governing CBD in Taiwan, we find that CBD is a classified as a pharmaceutical product and the growing of cannabis plants for any purposes, and the addition of CBD to cosmetic products, is prohibited
